Rapid HER2 cytologic fluorescence in situ hybridization for breast cancer using noncontact alternating current electric field mixing

Rapid HER2 cytologic fluorescence in situ hybridization for breast cancer using noncontact alternating current electric field mixing

Abstract Background Human epidermal growth factor receptor 2‐in situ hybridization (HER2‐ISH) is widely approved for diagnostic, prognostic biomarker testing of formalin‐fixed paraffin‐embedded tissue blocks. However, cytologic ISH analysis has a potential advantage in tumor samples such as pleural...

Full description

Bibliographic Details
Main Authors: Shin‐nosuke Watanabe, Kazuhiro Imai, Hiroshi Nanjo, Yuki Wakamatsu, Yoshihiko Kimura, Yoshihisa Katayose, Shuichi Kamata, Kaori Terata, Eriko Takahashi, Ayano Ibonai, Ayuko Yamaguchi, Hikari Konno, Misako Yatsuyanagi, Chiaki Kudo, Shinogu Takashima, Yoichi Akagami, Ryuta Nakamura, Yusuke Sato, Satoru Motoyama, Kyoko Nomura, Yoshihiro Minamiya
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Cancer Medicine
Subjects:
breast cancer
cytology
human epidermal growth factor receptor 2
in situ hybridization
noncontact alternating current electric field mixing
Online Access:https://doi.org/10.1002/cam4.3626

Internet

https://doi.org/10.1002/cam4.3626

Similar Items